← Back to House of Commons Debates

Medicines

09 September 2024

Lead MP

Karin Smyth

Debate Type

General Debate

Tags

Defence
Other Contributors: 10

At a Glance

Karin Smyth raised concerns about medicines in the House of Commons. A government minister responded. Other MPs also contributed.

How the Debate Unfolded

MPs spoke in turn to share their views and ask questions. Here's what each person said:

Lead Contributor

Opened the debate
The draft statutory instrument will amend the Human Medicines Regulations 2012 to expand access to naloxone, a lifesaving medication that reverses opioid overdose effects. It also updates references following the dissolution of Public Health England and the Health and Social Care Board. The legislation aims to save lives by allowing more services and professionals to provide take-home supplies of naloxone. The draft instrument proposes expanding the list of named providers who can supply naloxone without a prescription and establishing national registration services across the UK. Over 90% of responses to the Department’s consultation were in support, including recommendations from Dame Carol Black's independent review.

Government Response

Defence
Government Response
Stood in for the public health Minister and acknowledged broad agreement on the need for prevention measures across the House. Emphasised training and data reporting requirements will be attached to this measure, including safe administration of naloxone, storage, and how to train others.
Assessment & feedback
Summary accuracy

About House of Commons Debates

House of Commons debates take place in the main chamber of the House of Commons. These debates cover a wide range of topics including government policy, legislation, and current affairs. MPs from all parties can participate, question ministers, and hold the government accountable for its decisions.